跳至主要内容
临床试验/TCTR20200205007
TCTR20200205007已完成不适用

Serum cystatin C as a predictor of 90-day mortality in patients admitted with complications of cirrhosis

Department of Medicine, Phramongkutklao Hospital0 个研究点目标入组 62 人开始时间: 2020年2月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
62

研究概览

简要总结

Serum Cys is superior to MELD score, and the new MELD-Cys model is comparable to the MELD score in predicting mortality among patients with cirrhosis admitted with complications.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • •1. Cirrhosis by clinical and imaging
  • •2. Informed consent before enrollment
  • •3. Patient who is admitted in hospital

排除标准

  • •1. HCC outside Milan criteria or active cancer patient who is life expectancy less than 6 months
  • •2. End stage renal disease who received long term renal replacement therapy
  • •3. Pregnancy
  • •4. Hyperthyroidism
  • •5. Lack of written consent

研究者

相似试验